ChemMedChemPub Date : 2026-10-19DOI: 10.1002/cmdc.70547
Babak Kaboudin, Atefe Barati
{"title":"Therapeutic and Biomedical Applications of Dopamine-Derived Scaffolds: A Comprehensive Review","authors":"Babak Kaboudin, Atefe Barati","doi":"10.1002/cmdc.70547","DOIUrl":"10.1002/cmdc.70547","url":null,"abstract":"<p>Dopamine, a pivotal catecholamine, serves as a versatile scaffold in drug design due to its unique pharmacological profile and chemical reactivity. This review integrates evidence on the therapeutic applications of dopamine-derived compounds, ranging from their established roles in treating neurodegenerative disorders such as Parkinson's disease to emerging innovations in enzyme inhibition, gene delivery, and tissue engineering. Furthermore, we discuss structural modifications aimed at enhancing pharmacokinetic properties and brain bioavailability, alongside the utility of dopamine derivatives as molecular tracers in mapping neural architecture.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 20","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149222863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Design, Synthesis, and Biological Evaluation of Quinolin-2-One–Indole Schiff Base Hybrids as Potential EGFR-Targeted Anticancer Agents Against Breast and Ovarian Cancer","authors":"Prachita Gauns Dessai, Parixit Bhandurge, Celina Nazareth, Sahili Naik","doi":"10.1002/cmdc.70541","DOIUrl":"10.1002/cmdc.70541","url":null,"abstract":"<p>A series of new quinolin-2-one–indole Schiff base hybrids was designed, synthesized, and tested as potential anticancer agents targeting the epidermal growth factor receptor. The designed compounds were synthesized via a multistep synthetic route comprising phenylhydrazone formation, Fischer indole cyclization, Vilsmeier–Haack formylation, and subsequent Schiff base condensation. Structural elucidation was performed using IR, <sup>1</sup>H NMR, <sup>13</sup>C NMR, and mass spectral analysis. In silico studies demonstrated that the synthesized compounds exhibited strong binding affinities to both wild-type (PDB ID: 1M17) and mutant EGFR (PDB ID: 4ZAU), as evidenced by favorable docking scores, with PYd2 showing the strongest interaction. Molecular dynamics simulations over 100 ns further confirmed that the PYd2–EGFR complexes remained stable, maintaining consistent protein–ligand contacts and exhibiting stable RMSD and RMSF values throughout the simulation period. Predicted ADME-toxicity profiles demonstrated favorable drug-like properties, oral absorption, and acceptable toxicity profiles for most synthesized derivatives. In vitro anticancer evaluation against MDA-MB-231 and SK-OV-3 cell lines identified PYd2 as the most potent analog. ELISA-based studies demonstrated significant inhibition of EGFR expression and phosphorylation, while DAPI staining revealed characteristic apoptotic nuclear changes in treated cells. Overall, PYd2 showed favorable predicted EGFR binding and antiproliferative activity against both cancer cell lines.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 20","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149222879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2026-10-18DOI: 10.1002/cmdc.70535
Rebecca Deprez-Poulain, Anna K. H. Hirsch, Laura H. Heitman, Martin Missbach, Minh Thao Tran, Alessio Ciulli, Sereina Riniker, Tanja Poljak
{"title":"The 20th EFMC Short Course on Medicinal Chemistry Dedicated to Atypical Approaches Focusing on Protein Targets","authors":"Rebecca Deprez-Poulain, Anna K. H. Hirsch, Laura H. Heitman, Martin Missbach, Minh Thao Tran, Alessio Ciulli, Sereina Riniker, Tanja Poljak","doi":"10.1002/cmdc.70535","DOIUrl":"10.1002/cmdc.70535","url":null,"abstract":"<p>The 20<sup>th</sup> EFMC Short Course on Medicinal Chemistry took place from April 19–22, 2026, in Oegstgeest, near Leiden in the Netherlands. Rather than focusing on a single topic, this anniversary edition reviewed some atypical approaches in medicinal chemistry as well as looked back at the past 20 years and forward to the next decades. The course gathered 26 attendees as well as 7 instructors from Europe, from both industry and academia. We report here the key points of each of the five sessions and workshops from this anniversary edition.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 20","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149219772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2026-10-18DOI: 10.1002/cmdc.70528
Veronika Kost, Filippo Prencipe, Federica Panozzi, Veronica Salmaso, Sonja Kachler, Karl-Norbert Klotz, Elisabetta Coppi, Simone Adorinni, Stefano Moro, Anna Maria Pugliese, Stephanie Federico, Giampiero Spalluto, Tatiana Da Ros
{"title":"Tuning the Triazolotriazine Scaffold Toward Selective A3 Adenosine Receptor Antagonists: From Molecular Recognition to Neuroprotection","authors":"Veronika Kost, Filippo Prencipe, Federica Panozzi, Veronica Salmaso, Sonja Kachler, Karl-Norbert Klotz, Elisabetta Coppi, Simone Adorinni, Stefano Moro, Anna Maria Pugliese, Stephanie Federico, Giampiero Spalluto, Tatiana Da Ros","doi":"10.1002/cmdc.70528","DOIUrl":"10.1002/cmdc.70528","url":null,"abstract":"<p>A series of 2,5,7-trisubstituted [1,2,4]triazolo[1,5-<i>a</i>][1,3,5]triazines (TTs) was developed to identify selective A<sub>3</sub> AR antagonists. Guided by previous structure–activity relationship studies, the C2-furyl substituent was replaced with phenyl or 4-methoxyphenyl moieties to improve A<sub>3</sub> AR affinity and selectivity. C2 phenyl substitution, together with appropriate C5 and C7 amino substituents, critically modulates receptor recognition. In particular, benzylamino substitution at C5 markedly enhanced A<sub>3</sub> AR affinity, yielding compound <b>15</b> as the most potent antagonist of the series (<i>K</i><sub>i</sub> = 0.485 nM), whereas incorporation of a 4-methoxyphenyl group at C2 substantially improved subtype selectivity, exemplified by compound <b>30</b> (>2800-fold selective for A<sub>3</sub> AR). Molecular docking at the recently determined antagonist-bound structure of the A<sub>3</sub> AR rationalized these trends and identified key structural determinants of A<sub>3</sub> AR preference. The biological relevance of A<sub>3</sub> AR blockade was investigated in rat hippocampal slices subjected to oxygen-glucose deprivation. Compound <b>15</b> delayed anoxic depolarization and, when administered during ischemia, prevented its onset in most slices and promoted near-complete recovery of synaptic transmission. These findings identify TT derivatives as promising and highly selective A<sub>3</sub> AR antagonists with potential neuroprotective applications in cerebral ischemia.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 20","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149219715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2026-10-18DOI: 10.1002/cmdc.70531
Alexander S. Rich, Leela S. Dodda, Daniel J. Price
{"title":"Evaluating Machine Learning Affinity Prediction Methods on Novel Lead Optimization Data: A 15-PGDH Case Study","authors":"Alexander S. Rich, Leela S. Dodda, Daniel J. Price","doi":"10.1002/cmdc.70531","DOIUrl":"10.1002/cmdc.70531","url":null,"abstract":"<p>Recent machine learning (ML) methods for protein–ligand affinity prediction, such as Boltz-2 and AEV-PLIG, have been reported to approach free energy perturbation (FEP) accuracy on well-known benchmarks. Even short of that accuracy, ML-based potency models that fall between FEP and common docking scoring functions in accuracy and speed offer clear potential value. Here, we report a case study using recently disclosed data from four related ligand series targeting 15-hydroxyprostaglandin dehydrogenase (15-PGDH). We evaluate each ML method's predictive accuracy with a focus on when it could be used to influence synthetic priorities. AEV-PLIG performed poorly across most series, and adding literature 15-PGDH inhibitors to its training did not improve performance. Boltz-2 performed well on series most similar to published inhibitors in its training, achieving accurate cofolding (median ligand RMSD ≤0.81 Å) and rank order. However, for a series exploring a new region of the binding pocket, Boltz-2 sometimes generated less accurate poses and predicted all ligands in the series to be less potent than a published exemplar, despite experimental potency gains of up to 500x. These results highlight both the promise in well-characterized chemical space and limitations in the novel regions where computational guidance is most needed.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 20","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149219767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2026-10-14DOI: 10.1002/cmdc.70524
Marco Minneci, Barbara Farkaš, Adeyemi Rahman, Inga Nehlmeier, Amy Eichmann, Stefan Pöhlmann, Isabel Rozas
{"title":"Searching for Novel COVID19 Treatments: Towards Covalent TMPRSS2 Inhibitors.","authors":"Marco Minneci, Barbara Farkaš, Adeyemi Rahman, Inga Nehlmeier, Amy Eichmann, Stefan Pöhlmann, Isabel Rozas","doi":"10.1002/cmdc.70524","DOIUrl":"10.1002/cmdc.70524","url":null,"abstract":"<p><p>We present the design, synthesis and biophysical and biochemical evaluation of new guanidinium derivatives with potential as covalent inhibitors of Transmembrane Protease Serine 2 (TMPRSS2), aiming to find therapies against COVID-19. TMPRSS2 is a key protease for SARS-CoV-2 entry into host cells, making it a promising drug target since blocking viral entry, viral replication is stopped. We have designed five families of guanidinium derivatives with different scaffolds that would allow establishing covalent interactions with the target. The proposed structures were optimised for better binding and drug-like properties. Docking studies showed that some of the new compounds had improved binding scores over nafamostat. Physicochemical and ADME properties analysis indicated that most of the compounds exhibit favourable drug-like properties except for a small number that showed poor solubility or absorption. Different synthetic pathways were designed and optimised for the preparation of the five families, and the 40 compounds obtained were fully characterised. Unfortunately, in cell-based assays, none of the new compounds prepared effectively blocked SARS-CoV-2 entry, suggesting that further optimisation is needed. Overall, the work presented expands the chemical space for targeting TMPRSS2 and provides valuable insights for future antiviral drug development.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":"e70524"},"PeriodicalIF":3.5,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13659029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149163976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Inhibitors of PIM-1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints","authors":"Banty Kumar, Ankur Vaidya, Shweta Jain, Sanjeev Kumar Sahu, Preeti Patel, Vivek Asati","doi":"10.1002/cmdc.70533","DOIUrl":"https://doi.org/10.1002/cmdc.70533","url":null,"abstract":"<p>Pim-1, a carcinogenic threonine and serine kinase, inhibits apoptosis and advances the cell cycle. It is overexpressed in several human cancers. The proviral integration site of Moloney murine leukemia virus 1 is Pim-1. Previous studies have shown that the Pim-1 30-UTR regulates the stability of Pim-1 mRNA. Threonine and serine are identified as the proto-oncogene Pim-1 kinase. Pim-1 mediates numerous biological processes, including apoptosis, cell division, proliferation, and cancer. Pim-1-mediated anticancer activity has been reported in several analogs of thiazole/<i>bis</i>-thiazole, tetrazine, thiophenes, quinoline, pyrazolopyrimidine, 3-cyanopyridine, thiazolidine-2,4-dione, thieno[2,3-<i>b</i>]pyridine, triazolo[4,3-<i>b</i>]pyridazine, pyrazolo[1,5-<i>a</i>]pyrimidines, and pyrazolo[3,4-<i>b</i>]pyridine derivatives. Additionally, flavonoids and amino alcohol compounds that constitute Pim-1-mediated cancer therapy have also been identified thus far. Many compounds with Pim-1-mediated cytotoxicity have been discovered up to this point, and scientists are currently concentrating on bringing novel compounds with anticancer potential to the market.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 20","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149176975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2026-10-13DOI: 10.1002/cmdc.70506
Gyuzel Y. Mitronova, Vladimir N. Belov, Constanze Schmidt, Stephan E. Lehnart
{"title":"Multitarget Drug Design for Cardiovascular Disease: Bridging Chemistry and Medicine","authors":"Gyuzel Y. Mitronova, Vladimir N. Belov, Constanze Schmidt, Stephan E. Lehnart","doi":"10.1002/cmdc.70506","DOIUrl":"10.1002/cmdc.70506","url":null,"abstract":"<p>This review provides an overview of recent advances in the development of multitarget drugs (MTDs) for cardiac diseases, with a particular focus on emerging molecular scaffolds and their pharmacological properties. We discuss the fundamental principles of cardiac polypharmacology and multitarget drug design, highlighting key compound classes, such as 1,4-benzothiazepines, 1,4-dihydropyridines (DHPs), and polyphenol derivatives. Particular emphasis is placed on the relationship between the structural features and the pharmacological activity, efficacy, and therapeutic potential of these compounds.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13662224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149178302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2026-10-13DOI: 10.1002/cmdc.70521
Sandeep Bindra, T. M. Rangarajan, Della Grace Thomas Parambi, Sandeep Kumar, Jasha Momo H. Anal, Bijo Mathew
{"title":"Beyond Single-Target Therapy: Dual-Acting Cannabinoid Type-2 Receptor Modulation in Neurological Disorders","authors":"Sandeep Bindra, T. M. Rangarajan, Della Grace Thomas Parambi, Sandeep Kumar, Jasha Momo H. Anal, Bijo Mathew","doi":"10.1002/cmdc.70521","DOIUrl":"https://doi.org/10.1002/cmdc.70521","url":null,"abstract":"<p>Neurological disorders such as Alzheimer's disease, Parkinson's disease, and neuroinflammatory conditions involve complex, interconnected mechanisms, including neuroinflammation, oxidative stress, cholinergic dysfunction, and synaptic impairment. The cannabinoid type-2 receptor (CB2R), primarily expressed in immune and glial cells, has emerged as a promising therapeutic target due to its role in modulating neuroinflammation and providing neuroprotection without the psychoactive effects associated with CB1R activation. Recent research highlights the potential of dual-acting CB2R ligands that also modulate CB1R, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE), offering a multitarget approach to neurological disorders. Although CB1R expression was identified in 1993, significant progress in designing receptor modulators began in the 2000s, with recent focus expanding to autoimmune, metabolic, and cancer-related applications. This review summarizes advances in the design, synthesis, and structure–activity relationships of CB2R-targeting ligands, emphasizing dual- or multitarget agents with cholinesterase inhibitory activity. Key chemical scaffolds include synthetic cannabinoids, heterocyclic compounds, and hybrid molecules integrating cholinesterase pharmacophores. Molecular docking and in silico studies are discussed to elucidate ligand–receptor interactions, binding modes, and determinants of selectivity. Overall, CB2R-centric dual-acting ligands represent a promising strategy for addressing multifactorial neurological disorders.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 20","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149176942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChemMedChemPub Date : 2026-10-13DOI: 10.1002/cmdc.70514
Patrick Duchstein, Lorenz Früchtl, Annu Thomas, Dirk Zahn
{"title":"A Molecular Rationale for Tailoring the Growth Mechanisms of Biomimetic Calcium Oxalates: Guides to Simplified Proxies of Renal Stones?","authors":"Patrick Duchstein, Lorenz Früchtl, Annu Thomas, Dirk Zahn","doi":"10.1002/cmdc.70514","DOIUrl":"10.1002/cmdc.70514","url":null,"abstract":"<p>We present a combined molecular simulation and experimental study of the mechanisms of calcium oxalate monohydrate formation within a biomimetic matrix. Using a double-diffusion approach to feed calcium and oxalate ions into an agarose gel, we show how selective ion association to different crystal faces may guide the morphogenesis and surface charge of the precipitates. Our analyses rationalize two conceptually different growth mechanisms leading to the aggregation of crystallites in terms of negatively charged needles and positively charged platelets, respectively, whereas embedding organic macromolecules are related to the hosting of counterions. We argue that this reflects a key characteristic of renal stone formation, while benefiting from drastic reduction of system complexity. Hence, the biomimetic setup is suggested for both, ex situ formation of (much simplified) proxies to kidney/urinary stones and steps toward the understanding of growth factors for tailoring inner structure, size, and dispersion in water.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"21 19","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149178173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}